Avinger inc stock.
Hayward Pool Products Inc is a leading manufacturer of high-quality pool equipment, including pumps, filters, heaters, and cleaners. If you’re lucky enough to own one of their products, it’s important to keep it in good condition to ensure ...
Oct 26, 2023 · Avinger, Inc. REDWOOD CITY, CA / ACCESSWIRE / October 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular ... 14 thg 3, 2016 ... More than a year ago, image-guided catheter-based systems company Avinger priced an upsized IPO at $13 ... The latest pressure on the stock comes ...Reported on 10/26/23. Get the latest Avinger Inc (AVGR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... Dec 1, 2023 · Avinger, Inc. (NASDAQ:AVGR) posted its earnings results on Thursday, October, 26th. The medical device company reported ($2.92) earnings per share for the quarter, missing the consensus estimate of ($2.85) by $0.07. The medical device company had revenue of $1.82 million for the quarter, compared to analysts' expectations of $2.40 million. Aug 25, 2023 · REDWOOD CITY - Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced three podium presentations featuring the company's Lumivascular technology at The Amputation Prevention Symposium, held from August 16 through August 19 in Chicago ...
Avinger price target raised to $5 from $1.60 at H.C. Wainwright November 13, 2023TipRanks. Get Avinger Inc (AVGR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD).Nov 4, 2022 · 9.0000. 3,993. *Close price adjusted for splits. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for AVGR stock on Yahoo Finance. View daily, weekly or monthly format back to when Avinger, Inc. stock was issued.
John Simpson AVGR stock SEC Form 4 insiders trading. John has made over 5 trades of the Avinger Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently John sold 1,074,130 units of AVGR stock worth $268,533 on 13 November 2017.1,074,130 units of AVGR stock worth $268,533 on 13 November 2017.
View Avinger, Inc AVGR investment & stock information. Get the latest Avinger, Inc AVGR detailed stock quotes, stock data, Real-Time ECN, charts, ...The estimated Net Worth of Mark Weinswig is at least $981 Thousand dollars as of 18 September 2021. Mr. Weinswig owns over 16,667 units of Avinger Inc stock worth over $45,818 and over the last 13 years he sold AVGR stock worth over $368,626. In addition, he makes $566,750 as Chief Financial Officer at Avinger Inc.The estimated Net Worth of Himanshu Patel is at least $988 Thousand dollars as of 18 September 2022. Mr. Patel owns over 834 units of Avinger Inc stock worth over $7,123 and over the last 8 years he sold AVGR stock worth over $159,951. In addition, he makes $820,556 as Chief Technology Officer at Avinger Inc.UpTrade could be considered as a possible short-squeeze candidate due to the stock's high short-interest and low float of less than 900 thousand shares. Related News: What's Going On With Avinger Inc. Stock Today? UPTD Price Action: According to Benzinga Pro, TradeUP shares are up 42% at $17.15 at the time of publication. Image: …26 thg 10, 2023 ... (AP) — Avinger Inc. (AVGR) on Thursday reported a loss of $4.5 ... stock now? | Smart Investing · Does Amazon stock have more room to run ...
The estimated Net Worth of Himanshu Patel is at least $984 mil dollars as of 18 September 2022. Mr. Patel owns over 834 units of Avinger Inc stock worth over $3,612 and over the last 8 years he sold AVGR stock worth over $159,951. In addition, he makes $820,556 as Chief Technology Officer at Avinger Inc.
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD).
REDWOOD CITY, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for ...Price Targets are an analyst's best guess at where the stock will trade in 12 months. ... Avinger Inc (NASDAQ:AVGR) Add To Watchlist + Perks Buy Compare Brokers. $2.92. 0.07 [2.46%]Scheduled to Reconvene December 23, 2020. Avinger Strongly Encourages Stockholders to Immediately Vote FOR Proposal 3. REDWOOD CITY, CA / ACCESSWIRE / December 11, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that its ...Avinger Inc (NASDAQ:AVGR) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we'd rather spend our time researching ...REDWOOD CITY, CA / ACCESSWIRE / May 10, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the first quarter ended March 31, 2023.
AVGR | Complete Avinger Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.REDWOOD CITY, CA / ACCESSWIRE / May 10, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the first quarter ended March 31, 2023.Grading Avinger Inc Stock. Before you choose to buy, sell or hold Avinger Inc stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement.Avinger Inc stock performance at a glance. Check Avinger Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced presentations featuring the Company's Lumivascular, OCT-guided, technologies at the annual AMP (Amputation ...See Avinger, Inc. (AVGR) history of stock splits. Includes date and ratio.
Avinger (NASDAQ: AVGR) stock was up 47% yesterday followed by another 28% post market. AVGR stock was thus up 88% on the whole day, although this was a significant fallback from the peak rise of near 300%. ... As a background: “Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a …The estimated Net Worth of Donald A Lucas is at least $237 Thousand dollars as of 5 September 2019. Mr. Lucas owns over 4,602 units of Avinger Inc stock worth over $2,861 and over the last 18 years he sold AVGR stock worth over $233,759. In addition, he makes $0 as Independent Director at Avinger Inc.
About Avinger Inc. Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians ...May 22, 2023 · On May 18, 2023, Avinger, Inc. (the "Company") received notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") that the Company no longer satisfies the $2.5 million stockholders' equity requirement for continued listing on The Nasdaq Capital Market, or the alternatives to that requirement - a $35 million ... Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...AVGR Earnings Date and Information. Avinger last issued its quarterly earnings data on October 26th, 2023. The medical device company reported ($2.92) EPS for the quarter, missing analysts' consensus estimates of ($2.85) by $0.07. The business earned $1.82 million during the quarter, compared to analysts' expectations of $2.40 million.Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of ...Price Targets are an analyst's best guess at where the stock will trade in 12 months. ... Avinger Inc (NASDAQ:AVGR) Add To Watchlist + Perks Buy Compare Brokers. $2.92. 0.07 [2.46%]Avinger, Inc. AVGR shares are trading higher on Wednesday. The stock appears to be moving on continued upward momentum from the last two days.. What To Know: Avinger shares have gained nearly 175% since Monday when the company announced the commercial launch of its Tigereye ST image-guided chronic total …The Investor Relations website contains information about Avinger, Inc.'s business for stockholders, potential investors, and financial analysts.
Get the latest Avinger (AVGR) stock forecast for tomorrow and next week. Stay ahead of the game with our Avinger stock price prediction for 2025 and 2030.
Insiders trading at Avinger Inc. Over the last 9 years, insiders at Avinger Inc have traded over $4,931,811 worth of Avinger Inc stock and bought 65,650 units worth $291,405 . The most active insiders traders include John B Ph D Md Simpson, James Cullen, and Jeffrey M Soinski.On average, Avinger Inc executives and independent …
Investor Contact: Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment ...Jan 12, 2022 · REDWOOD CITY, CA / ACCESSWIRE / January 12, 2022 / Avinger, Inc. The shares of Preferred Stock will have a stated value of $1,000 per share and are convertible into an aggregate of 19,000,000 ... The estimated Net Worth of Jeffrey M Soinski is at least $1.33 Milión dollars as of 18 September 2022. Mr. Soinski owns over 1,250 units of Avinger Inc stock worth over $34,643 and over the last 8 years he sold AVGR stock worth over $5,411. In addition, he makes $1,292,540 as President, Chief Executive Officer a Director at Avinger Inc.AVGR Stock Message Board for Investors. Avinger Inc. Stock Price, News and Company Updates. Message Board Total Posts: 75Insiders trading at Avinger Inc. Over the last 9 years, insiders at Avinger Inc have traded over $4,931,811 worth of Avinger Inc stock and bought 65,650 units worth $291,405 . The most active insiders traders include John B Ph D Md Simpson, James Cullen, and Jeffrey M Soinski.On average, Avinger Inc executives and independent …Nov 30, 2023 · Company Description. Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence ... Is Avinger Inc (AVGR) Stock About to Get Hot Thursday? InvestorsObserver - Sep 28, 2023, 10:58AM. Avinger raises $5.3M via at-the-market facility. Seeking Alpha - Sep 27, 2023, 8:18AM.Find the latest Avinger, Inc. (AVGR) stock quote, history, news and other vital information to help you with your stock trading and investing.
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Aug 8, 2022 · Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis ... Avinger, Inc. REDWOOD CITY, CA / ACCESSWIRE / October 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular ...The largest individual shareholder of Apple, Inc. is Arthur D. Levinson, with over 1.1 million shares, as of late November 2014. Levinson is currently the non-executive Chairman of the Board of directors for Apple. He joined the Board in 20...Instagram:https://instagram. fractional ownership real estate companiesonl'best stock movers todayprivate race track Get the latest Avinger (AVGR) stock forecast for tomorrow and next week. Stay ahead of the game with our Avinger stock price prediction for 2025 and 2030. average real estate management feesfranklin income funds Shares of Avinger Inc. skyrocketed 63.5% on heavy volume in morning trading Monday, enough to make them the biggest gainers trading on major U.S. exchanges, after the medical device company ...Dec 11, 2020 · Scheduled to Reconvene December 23, 2020. Avinger Strongly Encourages Stockholders to Immediately Vote FOR Proposal 3. REDWOOD CITY, CA / ACCESSWIRE / December 11, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that its ... cigna dental discount Dec 1, 2023 · According to 1 stock analyst, the 12-month stock price forecast for Avinger stock is $5.00, which predicts an increase of 71.82%. On average, analysts rate Avinger stock as a strong buy. Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and ...